mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
0.15 |
0.002 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
0.002 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.14 |
0.002 |
mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.003 |